Ji Xiang An
Chairman at Changchun BCHT Pharmaceuticals Co. Ltd.
Ji Xiang An active positions
| Companies | Position | Start | End |
|---|---|---|---|
GeneScience Pharmaceuticals Co., Ltd.
 GeneScience Pharmaceuticals Co., Ltd. Pharmaceuticals: MajorHealth Technology GeneScience Pharmaceuticals Co., Ltd. engages in the production and sale of biopharmaceutical products. Its products include bioengineering products such as recombinant human growth hormones, active pharmaceutical ingredients such as tripplein acetate and alprostadil, freeze-dried powder injections, small volume injections, biological product intermediates, and medical devices. The company was founded by Lei Jin in 1996 and is headquartered in Changchun, China. | Director/Board Member | 2014-03-17 | - |
| Changchun BCHT Pharmaceuticals Co. Ltd. | Chairman | 2013-01-21 | - |
Jilin Huakang Pharmaceutical Co. Ltd.
 Jilin Huakang Pharmaceutical Co. Ltd. Pharmaceuticals: MajorHealth Technology Part of Changchun High & New Technology Industries (Group), Inc., Jilin Huakang Pharmaceutical Co. Ltd. is a Chinese pharmaceutical company that manufactures pharmaceutical products. The private company is based in Dunhua, China. | Director/Board Member | 2014-03-11 | - |
Changchun Baiyi Pharmaceutical Co., Ltd.
 Changchun Baiyi Pharmaceutical Co., Ltd. Medical SpecialtiesHealth Technology Part of Changchun High-Tech Industry (Group) Co., Ltd., Changchun Baiyi Pharmaceutical Co., Ltd. is a private company that manufactures biological pharmaceutical products. Changchun Baiyi Pharmaceutical Co., Ltd. is based in Changchun, China. Changchun Baiyi Pharmaceutical Co. was acquired by Changchun BCHT Biotechnology Co. on June 14, 2013 for $1.67 million. | Director/Board Member | 2013-07-31 | - |
Career history of Ji Xiang An
Former positions of Ji Xiang An
| Companies | Position | Start | End |
|---|---|---|---|
| CHANGCHUN BCHT BIOTECHNOLOGY CO. | Chairman | 2004-02-29 | 2021-07-08 |
| CHANGCHUN HIGH-TECH INDUSTRY (GROUP) CO., LTD. | Director/Board Member | 2014-12-28 | 2021-06-22 |
| Chief Executive Officer | 2018-06-25 | 2021-06-22 | |
| Corporate Officer/Principal | 2014-12-28 | - |
Statistics
International
| China | 7 |
Operational
| Director/Board Member | 4 |
| Chairman | 2 |
| Chief Executive Officer | 1 |
Sectoral
| Health Technology | 6 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Listed companies | 2 |
|---|---|
| CHANGCHUN HIGH-TECH INDUSTRY (GROUP) CO., LTD. | Health Technology |
| CHANGCHUN BCHT BIOTECHNOLOGY CO. | Health Technology |
| Private companies | 4 |
|---|---|
GeneScience Pharmaceuticals Co., Ltd.
GeneScience Pharmaceuticals Co., Ltd. Pharmaceuticals: MajorHealth Technology GeneScience Pharmaceuticals Co., Ltd. engages in the production and sale of biopharmaceutical products. Its products include bioengineering products such as recombinant human growth hormones, active pharmaceutical ingredients such as tripplein acetate and alprostadil, freeze-dried powder injections, small volume injections, biological product intermediates, and medical devices. The company was founded by Lei Jin in 1996 and is headquartered in Changchun, China. | Health Technology |
| Changchun BCHT Pharmaceuticals Co. Ltd. | |
Jilin Huakang Pharmaceutical Co. Ltd.
Jilin Huakang Pharmaceutical Co. Ltd. Pharmaceuticals: MajorHealth Technology Part of Changchun High & New Technology Industries (Group), Inc., Jilin Huakang Pharmaceutical Co. Ltd. is a Chinese pharmaceutical company that manufactures pharmaceutical products. The private company is based in Dunhua, China. | Health Technology |
Changchun Baiyi Pharmaceutical Co., Ltd.
Changchun Baiyi Pharmaceutical Co., Ltd. Medical SpecialtiesHealth Technology Part of Changchun High-Tech Industry (Group) Co., Ltd., Changchun Baiyi Pharmaceutical Co., Ltd. is a private company that manufactures biological pharmaceutical products. Changchun Baiyi Pharmaceutical Co., Ltd. is based in Changchun, China. Changchun Baiyi Pharmaceutical Co. was acquired by Changchun BCHT Biotechnology Co. on June 14, 2013 for $1.67 million. | Health Technology |
- Stock Market
- Insiders
- Ji Xiang An
- Experience
